4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-25-112045
Options or other derivatives
- CHIEF OPERATING OFFICER acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Christoph Lawrence CHIEF OPERATING OFFICER | 2025-08-26 | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…